These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 31734746)
1. CRISPR off-targets: a question of context. Haeussler M Cell Biol Toxicol; 2020 Feb; 36(1):5-9. PubMed ID: 31734746 [No Abstract] [Full Text] [Related]
2. Understanding off-target effects through hybridization kinetics and thermodynamics. Nazipova NN; Shabalina SA Cell Biol Toxicol; 2020 Feb; 36(1):11-15. PubMed ID: 31823200 [No Abstract] [Full Text] [Related]
3. Refining CRISPR-based genome and epigenome editing off-targets. Luo Y Cell Biol Toxicol; 2019 Aug; 35(4):281-283. PubMed ID: 31227932 [No Abstract] [Full Text] [Related]
4. Foresight is 2020: Ten Bold Predictions for the New CRISPR Year. Barrangou R CRISPR J; 2019 Dec; 2(6):341-342. PubMed ID: 31860348 [No Abstract] [Full Text] [Related]
5. Development and application of CRISPR/Cas9 technologies in genomic editing. Zhang C; Quan R; Wang J Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822 [TBL] [Abstract][Full Text] [Related]
6. Keeping our eyes on CRISPR: the "Atlas" of gene editing. Wang W; Hou J; Zheng N; Wang X; Zhang J Cell Biol Toxicol; 2019 Aug; 35(4):285-288. PubMed ID: 31165372 [No Abstract] [Full Text] [Related]
7. Radical Technology Meets Radical Application: An Interview with George Church. Davies K; Church GM CRISPR J; 2019 Dec; 2(6):346-351. PubMed ID: 31860351 [No Abstract] [Full Text] [Related]
8. The Biology and Application Areas of CRISPR Technologies. Adli M J Mol Biol; 2019 Jan; 431(1):1-2. PubMed ID: 30447221 [No Abstract] [Full Text] [Related]
9. Sharpening the CRISPR Toolbox. Barrangou R CRISPR J; 2020 Dec; 3(6):421. PubMed ID: 33346716 [No Abstract] [Full Text] [Related]
10. Thinking About CRISPR: The Ethics of Human Genome Editing. Barrangou R CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676 [No Abstract] [Full Text] [Related]
11. CRISPR to the Core. Lambert LJ CRISPR J; 2020 Dec; 3(6):433. PubMed ID: 33346714 [No Abstract] [Full Text] [Related]
15. Targeted Base Editing Systems Are Available for Plants. Marzec M; Hensel G Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156 [TBL] [Abstract][Full Text] [Related]
16. Directed Evolution of CRISPR-Cas9 Base Editors. Winter J; Perez-Pinera P Trends Biotechnol; 2019 Nov; 37(11):1151-1153. PubMed ID: 31623959 [TBL] [Abstract][Full Text] [Related]
19. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review). Alagoz M; Kherad N Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995 [TBL] [Abstract][Full Text] [Related]
20. A CRISPR Moratorium Isn't Enough: We Need a Boycott. Hough SH; Ajetunmobi A CRISPR J; 2019 Dec; 2(6):343-345. PubMed ID: 31860353 [No Abstract] [Full Text] [Related] [Next] [New Search]